COMP <GO>
ALB vs NEM // RSI-14 & 200D SMA MOMENTUM
Albemarle Corporation (NYSE) VS. Newmont Corporation (NYSE) • 15-METRIC TALLY: ALB 2
— NEM 12
▲ RSI-14 & 200D SMA MOMENTUM LEADER: NEM
LAST: $91.00 (-2.43%) • MKT CAP: $11.01B
rsi-technicals
32.0
LAST: $106.61 (-4.64%) • MKT CAP: $116.18B
rsi-technicals
36.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALB VS. NEM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALB | NEM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 13.00% | 41.00% | -28.00 | NEM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.60% | 21.80% | -24.40 | NEM | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 11.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 6.29% | 8.02% | -1.73 | NEM | /fcf-yield <GO> |
| Operating Margin | -7.10% | 38.10% | -45.20 | NEM | /operating-margins <GO> |
| Net Profit Margin | -9.90% | 31.30% | -41.20 | NEM | /net-margins <GO> |
| Revenue Growth (YoY) | -4.40% | 21.30% | -25.70 | NEM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.73% | 0.95% | +0.78 | ALB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.64 | 4.16 | -2.52 | NEM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | NEM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 7.00% | -0.10 | ALB | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 32.0 | 36.1 | -4.08 | NEM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 1.04 | -0.03 | NEM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.0x | 13.8x | +6.20 | NEM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.01B | $116.18B | -$105.18B | NEM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALB REV | NEM REV | ALB GROSS % | NEM GROSS % | ALB FCF | NEM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.14B | $22.67B | 13.0% | 44.0% | $692.5M | $9.31B |
| FY 2024 | $5.38B | $18.68B | 1.2% | 44.0% | -$992.7M | $5.52B |
| FY 2023 | $9.62B | $11.81B | 44.0% | 44.0% | $893.8M | $2.23B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALB // BETA 1.01
NEM // BETA 1.04